Complete Serum-Free Medium Kit With RocketFuel™ (10 pack)

Certificate #: SF-4Z0-500-10


Kit consists of 1- 500mL CSC Serum-Free Medium, 1- 8mL vial of RocketFuel™ (containing animal derived growth factors), and 1- 10mL vial of Attachment Factor™. This becomes a complete medium once activated with the included RocketFuel™ supplement. SF-4Z0-500 is Certified and intended for experimental application. CSC media and reagents are sterile, made with WFI and all components are cGMP and ISO Compliant.

Available Formats

Available in one 500 mL container or a 10 pack of 500 mL containers.

Appropriate Use

Certified for use with more than 100 human and animal cell cultures and cell lines including these CSC and ACBRI Certified cells:

  Bone Marrow Cells (CFU-F and Erythroid Burst Cultures)
  Connective Tissue Cells
  Endothelial Cells ( Aortic, Arterial, Coronary Artery, Vascular and Venous)
  Fetal Lung Cells
  Embryonic and Adult Stem Cells
  Fibroblast Cells
  Glomerular Mesangial Cells
  Immortalized / Tumor-derived Mesenchymal Cells
  Microvascular Cells (Cerebral, Coronary, Dermal, Glomerular, Liver, Lung and Retinal)
  Smooth Muscle Cells
  Tumor Neovascular Cells
  Bovine and Porcine large vessel and microvessel Endothelial Cells

Characteristics of CSC Serum-Free Medium:

CSC Medium contains no added hormones

CSC Medium contains no antibiotics; however, Bac-Off® (Ciprofloxacin), Catalog #4Z0-643, is the recommended antibiotic for all CSC Medium.

Use of Bovine Serum is no longer necessary. CSC Serum-Free Medium does not contain bovine-derived components. Human serum albumin and other components of human origin are specified by the formulation.

RocketFuel™ Supplement is supplied sealed in a non-oxidizing atmosphere. Plasma lipoprotein in RocketFuel™ is subject to oxidation upon contact with room air. The expiration date refers to unopened refrigerated storage of RocketFuel™, the metric being inactivation of growth factor and oxidation of lipoprotein. Cellular binding of oxidized lipoproteins may be toxic to your cells. Do not freeze CSC Serum-Free Medium or RocketFuel™ supplements. The apoprotein is separated from lipoprotein by freezing, making binding to the receptor impossible, and may result in toxicity.

Special Requirements of the Serum-Free Environment:  The in vitro requirements and culture procedures for cells employed in serum-free medium differ in several important ways from those appropriate for cells maintained in more traditional serum-containing cell culture. Use of Serum changes the phenotype of the cell.  Information is transduced, processed, and physiologic response motifs are mediated by interaction with the paracellular microenvironment. Absent local or systemic injury, cells never “see” biologically active products of the clotting cascade and/or mediators of pathology produced by leukocyte degranulation. Among the significant benefits of Serum-Free cell culture is that, in principle, it is possible to eliminate artifacts resultant from indiscriminate cellular “response to injury”. CSC Serum-Free Medium was engineered from CSC Serum-Containing Medium, providing the components necessary for characterization, housekeeping metabolism, growth-factor dependent proliferation, and cell-specific experimental response.

Companion Products

Use of Attachment Factor™ is strongly recommended. Phenotypic and physiologic response motifs are mediated in vivo by cells from information transduced from the extracellular compartment. Culture of differentiated, polar, anchorage dependent cells in any medium requires attention to information processed by the cell from the extracellular matrix (ECM). Attachment Factor™ is an analog for the Natural ECM, provides information to the cell, and helps mediate these processes. Phenol red is NOT included in the formulation. Refer to the CSC Certificate for Attachment Factor™.

Use of the Passage Reagent Group™ (PRG) is strongly recommended. Culture of fastidious cells in any medium requires careful formulation and calibration of reagents in order to detach cells for passage without excessive cytoskeletal and membrane damage. Trypsin is not “inactivated” by serum: the reduction of enzymatic activity on cell membranes is (at best) competitive and may be ineffective. Other enzymes (chymotrypsin, cathepsins, neutral proteases, etc.) not inactivated by serum in commercial (1:250) trypsin preparations make “inactivation” with serum during passage illogical. This PRG was engineered to meet the special challenges of modern cell culture, where thoughtful management of phenotype is important. Refer to the CSC Certificate for PRG.

Use of CSC Cell Freezing Medium™ is strongly recommended.  Cell Freezing Medium™ is formulated using conditioned CSC Medium with DMSO as the principal cryoprotective agent. CSC Cell Freezing Medium™ is qualified by CSC and ACBRI for freezing cells whether cultured in serum-free or serum containing medium. Refer to the CSC Certificate for Cell Freezing Medium™.

Handling and Storage

Medium StorageDo Not Freeze Serum-Free Medium or RocketFuel™ Supplement.

Upon receipt, immediately refrigerate the medium and supplements. Once the unit is activated, or any component of the medium kit is opened, the shelf life is 30 days at refrigerated (4 - 8°C) temperatures.

Cell Storage

Remove the vial(s) from the dry ice shipping container and immediately transfer to liquid nitrogen.  ALWAYS store cells under liquid nitrogen. Inapparent yet severe damage to membrane and cytoskeletal components results from chronic temperature fluctuations.

Additional Information

Thawing and Feeding Cells 

  1. Activate CSC Serum-Free Medium with CSC RocketFuel™:  8mL vial of RocketFuel™ activates 500mL Serum-Free Medium.
  2. Warm sufficient activated CSC Serum-Free Medium to 37°C in a water bath.
  3. Thaw the vial(s) of cells by immersing in a 37°C water bath. Observe carefully with gentle agitation and remove from the water bath just before the last of the ice disappears: this ensures that the cells are always kept close to the triple-point of water.
  4. Cleanse the vial(s) with 90% ethanol using a sterile 2X2. 
  5. Immediately transfer the contents of the vial to at least 10 volumes of ice-cold Medium in a sterile centrifuge tube. Keep in an ice/water bath throughout to maintain triple-point temperature: cell viability is negatively affected by temperature excursions.
  6. Centrifuge 100-200 X g, 5-7 minutes refrigerated.
  7. Aspirate and discard supernatant. Leave 100-150 µl fluid to cover the pellet.
  8. Loosen the cell pellet by flicking with fingers.
  9. Count and adjust cell concentration at this time per your usual protocol.
  10. Prepare the new culture surface using Attachment Factor™.
       (a) Warm Attachment Factor™ to 37°C in the water bath.
       (b) Wet the culture surface to be inoculated with Attachment Factor™.
       (c) Aspirate and discard excess. Rinsing and/or drying are NOT necessary.
    The culture may be inoculated at once.
  11. Re-suspend cells in CSC Complete Serum-Free Medium warmed to 37
  12. Seed on a tissue culture surface freshly coated with Attachment Factor™.
  13. Incubate @ 37°C, 5% CO2, 100% humidity.
  14. The vial of cells seeds a 75cm sq culture.

For Cell Passage

Refer to Passage Reagent Group™ instructions for more details.

  • To feed, aspirate (and discard) spent medium. Add fresh CSC Serum-Free Medium.
  • Feed at 12-24 hours and at least every 48 hours thereafter.
  • As cultures approach confluence, daily feeding should be considered.


PMID Title Author Year


Arg-Gly-Asp (RGD)-Modified E1A/E1B Double Mutant Adenovirus Enhances Antitumor Activity in Prostate Cancer Cells In Vitro and in Mice

Yue-Hong Shen



Optimization of an in vitro human blood–brain barrier model: Application to blood monocyte transmigration assays

Alexandre Paradis


Ascorbic Acid Prevents High Glucose-induced Apoptosis in Human Brain Pericytes

James M. May



S100A4 is upregulated in proliferative diabetic retinopathy and correlates with markers of angiogenesis and fibrogenesis

Ahmed M. Abu El-Asrar



Isolation of purified H and L polypeptide chains from guinea-pig gamma-2-immunoglobulin after mild reduction.

Lamm ME



Synthesis and biological activity of NOSH-naproxen (AVT-219) and NOSH-sulindac (AVT-18A) as potent anti-inflammatory agents with chemotherapeutic potential

Ravinder Kodela



Alterations of Retinal Vasculature in Cystathionine-Beta-Synthase Mutant Mice, a Model of Hyperhomocysteinemia

Amany Tawfik


Prevention of VEGF-induced growth and tube formation in human retinal endothelial cell by aldose reductase inhibition

Umesh CS Yadav



Localization of dichlorofluorescin in cardiac myocytes: implications for assessment of oxidative stress

Luther M. Smith

21372496 Protective effect of photodegradation product of niredipine against tumor necrosis factor alpha-induced oxidative stress in human glomerular endothelial cells Yayoi Fukuhara 2011
17953673 Soluble aggregates of the amyloid-beta protein activate endothelial monolayers for adhesion and subsequent transmigration of monocyte cells Francisco J. Gonzalez-Valasquez 2007
15528360 HIV-1 Tat-Mediated Effects on Focal Adhesion Assembly and Permeability in Brain Microvascular Endothelial Cells Shalom Avraham 2004
15383690 Hyaluronate Inhibits the Interliukin-1beta-Induced Expression of Matrix Metalloproteinase (MMP)-1 and MMP-3 in Human Synovial Cells Akiko Sasaki 2004
15618195 mRNA Expression and Amino Acid Transport Characteristics of Cultured Human Brain Microvascualr Endothelial Cells (hBME) Nouo Umeki 2002
12670949 Beta3-Adrenergic Receptors Regulate Retinal Endothelial Cell Migration and Proliferation Jena J. Steinle 2003
11751915 Characterization of Endocrine Gland-derived Vascular Endothelial Growth Factor Signaling in Adrenal Cortex Capillary Endothelial Cells Napoleone Ferrara 2002


Please read our Terms and Conditions.


Copyright © 1997-2017 Cell Systems. All Rights reserved